# Dexamethasone in Total Knee and Total Hip Arthroplasty

> **NCT02760043** · PHASE2,PHASE3 · UNKNOWN · sponsor: **University Health Network, Toronto** · enrollment: 314 (estimated)

## Conditions studied

- Total Knee Arthroplasty
- Total Hip Arthroplasty
- Osteoarthritis

## Interventions

- **DRUG:** Dexamethasone
- **OTHER:** 0.9% NaCl Placebo
- **DRUG:** LIA Combination Mixture

## Key facts

- **NCT ID:** NCT02760043
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-04
- **Primary completion:** 2018-10
- **Final completion:** 2018-10
- **Target enrollment:** 314 (ESTIMATED)
- **Last updated:** 2017-11-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02760043

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02760043, "Dexamethasone in Total Knee and Total Hip Arthroplasty". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02760043. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*